Please select a press release to review from the following options:
June 3, 2010
Viral Genetics Issues Company Update for First Half of 2010.
Click here for more.
May 26, 2010
Viral Genetics Appoints Dr. Baruch S. Blumberg to its Advisory Board.
Click here for more.
April 19, 2010
Emerging Technology Fund awards $750K to new Georgetown research facility.
Click here for more.
April 19, 2010
Viral Genetics Opens Lab in Texas: Lead Scientist Awarded $750,000 Grant.
Click here for more.
April 12, 2010
UCCS and Texas A&M Health Science Center Join to Advance Disease Treatment.
Click here for more.
February 11, 2010
Viral Genetics CEO Issues State of the Company Update.
Click here for more.
December 21, 2009
Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at Pinksheets.com
Click here for more.
December 8, 2009
New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies.
Click here for more.
December 3, 2009
Viral Genetics Licenses Immune Disease Therapeutic Platforms from University of Colorado.
Click here for more.
September 16, 2009
Viral Genetics' Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference.
Click here for more.
August 31, 2009
Beacon Equity Issues Technical Trading Overview for Viral Genetics Inc.
Click here for more.
August 26, 2009
Viral Genetics Completes Second Major Debt Conversion.
Click here for more.
August 26, 2009
Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases.
Click here for more.
August 11, 2009
Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium.
Click here for more.
August 7, 2009
Viral Genetics Creates Subsidiary to Develop Cancer Therapy.
Click here for more.
July 13, 2009
Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances.
Click here for more.
July 8, 2009
Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website.
Click here for more.
May 21, 2009
Viral Genetics Has Option Under Issued Key Patent for Cancer Drug.
Click here for more.
May 20, 2009
CORRECTION: Viral Genetics Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
Click here for more.
March 18, 2009
Viral Genetics Successfully Secures Grant for New Lyme Research Study.
Click here for more.
January 21, 2009
Dr. Leslie Z. Benet, An Internationally Recognized Expert in Drug Development, Has Joined Advisors at Viral Genetics.
Click here for more.
December 18, 2008
AIDS Nobel Laureate Joins Viral Genetics.
Click here for more.
November 19, 2008
Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.
Click here for more.
October 21, 2008
Viral Genetics, Inc. Releases Initial Findings of Lyme Disease Study.
Click here for more.
October 08, 2008
Viral Genetics, Inc. Invited to Present New Model, Initial Findings of Lyme Disease Study at Prestigious ILADS Conference.
Click here for more.
September 10, 2008
New Study Building off Viral Genetics' Research Aims to Unlock the Mysteries behind Lyme Disease and Other Immune Based Diseases Including HIV/AIDS.
Click here for more.
September 02, 2008
Form 8-K for VIRAL GENETICS INC /DE/. Unregistered Sale of Equity Securities, Financial Statements and Exhibits.
Click here for more.
August 19, 2008
Viral Genetics, Inc. Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at Prestigious IHV Meeting.
Click here for more.
August 08, 2008
Unregistered Sale of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities.
Click here for more.
August 06, 2008
Viral Genetics, Inc. Appoints C. Everett Koop as Special Advisor to Board of Directors.
Click here for more.
July 08, 2008
Unregistered Sale of Equity Securities, Financial Statements and Exhibits.
Click here for more.
March 19, 2008
Marshall C. Phelps, Richard T. Gerstner and Anthony Freda, Jr. Join Viral Genetics, Inc. Business Advisory Board and Invest in Private Placement.
Click here for more.
March 12, 2008
Dutton Associates Announces Investment Opinion: Viral Genetics Rating At Neutral In Update Coverage By Dutton Associates.
Click here for more.
February 05, 2008
Viral Genetics Updates Progress on Technology Acquired From University of Colorado.
Click here for more.
December 20, 2007
Viral Genetics Announces Licensing Deal With University of Colorado and V-Clip Pharmaceuticals, Inc.
Click here for more.
August 2, 2007
Viral Genetics Appoints Scientific Development Manager to Focus on Translational Studies.
Click here for more.
April 17, 2007
Viral Genetics Builds African Advisory Team.
Click here for more.
March 21, 2007
Viral Genetics Updates Scientific Milestones.
Click here for more.
March 13, 2007
Viral Genetics Restructures Convertible Debentures.
Click here for more.
January 25, 2007
Dutton Associates Announces Investment Opinion: Viral Genetics rating speculative buy in upgrade by Dutton Associates.
Click here for more.
January 09, 2007
Viral Genetics identifies crucial peptides for potential HIV/AIDS Drug.
Click here for more.
December 07, 2006
Viral Genetics to Present at New York Society of Security Analysts 10th Annual Biotech and Specialty Pharmaceuticals conference.
Click here for more.
November 02, 2006
Viral Genetics to Present at Rodman & Renshaw Healthcare Conference and The PIPEs Conference.
Click here for more.
October 30, 2006
Viral Genetics' AIDS Study Results to Be Presented at Institute of Human Virology's 2006InternationalMeeting.
Click here for more.
October 10, 2006
Dutton Associates Announces Investment Opinion.
Click here for more.
October 03, 2006
Viral Genetics Adds Two Harvard Specialists to Scientific Advisory Board.
Click here for more.
September 26, 2006
Viral Genetics to Present at EdgeWater Investment Conference.
Click here for more.
September 26, 2006
Viral Genetics to Exhibit at ICAAC.
Click here for more.
September 25, 2006
Viral Genetics Appoints Dr. Eric S. Rosenberg Chairman of Scientific Advisory Board.
Click here for more.
September 8, 2006
Viral Genetics Expands Communications to Mark US Development Program .
Click here for more.
August 11, 2006
Viral Genetics' AIDS Study Results at XVI International AIDS Conference.
Click here for more.
July 24, 2006
Viral Genetics' AIDS Study Yields Encouraging Results.
Click here for more.
June 19, 2006
Viral Genetics Announces Results of South African Study of VGV-1.
Click here for more.
April 21, 2006
Viral Genetics Updates on Release of Results of Phase III Study and Market Activity.
Click here for more.
March 31, 2006
Viral Genetics Updates on Release of Results of Phase III Study of VGV-1 for the Treatment of HIV Infection.
Click here for more.
March 29, 2006
Viral Genetics, Inc. Completes Convertible Debt Financing.
Click here for more.
February 22, 2006
Viral Genetics, Inc. Names Elizabeth Hoffman, PhD. to Board of Directors.
Click here for more.
January 11, 2006
Dr. Robert Siegel Named to Viral Genetics, Inc. Scientific and Medical Advisory Board.
Click here for more.
December 14, 2005
Viral Genetics Updates on South African Clinical Development Initiatives.
Click here for more.
June 1, 2005
Dr. Louis W. Sullivan, M.D., Joins Scientific and Medical Advisory Board of Viral Genetics, Inc.
Click here for more.
